An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects

AimsThe association of overweight status and cardiovascular disease is not clear. In this study we aimed to investigate coronary atherosclerotic disease, evaluated as coronary artery calcium score (CACs), in overweight patients with or without abdominal obesity as defined by waist-to-hip ratio (WHR).MethodsWe enrolled 276 patients aged between 40 and 70 years, with a body mass index of 25–29.9 kg/m2 and at least one cardiovascular risk factor. Exclusion criteria were history of diabetes, cardiovascular or renal disease. Patients were stratified in high WHR (H-WHR) or low WHR (L-WHR) group according to WHR (≥ 0.85 for women and ≥ 0.90 for men) and underwent multi-detector computed tomography for CACs. Mean carotid intima-media thickness (IMT) and plaque presence were equally assessed.ResultsCACs was higher in the H-WHR group compared to L-WHR (9.05 [0.0–83.48] vs 0.0 [0.0–64.7] AU, p < 0.01); the prevalence of CACs > 0 in the H-WHR group was significantly higher than subjects with L-WHR (59.6% vs 38.5%, p < 0.001). Moreover, H-WHR group had higher mean IMT (0.64 [0.56–0.72] vs 0.59 [0.55–0.67] mm, p < 0.05) and higher carotid plaque prevalence (63.7% vs 50.8%, p < 0.05) compared to subjects with L-WHR. Logistic regression showed that H-WHR was associated with presence of CACs and carotid plaque (p < 0.01). In a multiple linear regression, WHR was positively associated with CACs and IMT (p < 0.01).ConclusionsH-WHR is a marker of coronary and peripheral atherosclerotic burden in overweight patients.

[1]  John A. Rumberger,et al.  Interplay of Coronary Artery Calcification and Traditional Risk Factors for the Prediction of All-Cause Mortality in Asymptomatic Individuals , 2012, Circulation. Cardiovascular imaging.

[2]  M. Fasshauer,et al.  Insulin-sensitive obesity. , 2010, American journal of physiology. Endocrinology and metabolism.

[3]  J. Seidell Prevalence and time trends of obesity in Europe , 2002, Journal of endocrinological investigation.

[4]  J. Hokanson,et al.  Measurement of abdominal fat by CT compared to waist circumference and BMI in explaining the presence of coronary calcium , 2004, International Journal of Obesity.

[5]  D. McGee,et al.  Body mass index and mortality: a meta-analysis based on person-level data from twenty-six observational studies. , 2005, Annals of epidemiology.

[6]  Contribution of gender and body fat distribution to inflammatory marker concentrations in apparently healthy young adults , 2012, Inflammation Research.

[7]  S. Yusuf,et al.  Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study , 2005, The Lancet.

[8]  Sekar Kathiresan,et al.  Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease , 2017, JAMA.

[9]  D. Goff,et al.  Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment. , 2016, Journal of the American College of Cardiology.

[10]  T. Hansen,et al.  Measures of overweight and obesity and risk of cardiovascular disease: a population-based study , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[11]  S. Grundy,et al.  Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[12]  S. Grundy,et al.  Clinical Management of Metabolic Syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management , 2004, Arteriosclerosis, Thrombosis and Vascular Biology.

[13]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[14]  A Ross Naylor,et al.  2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed b , 2018, European heart journal.

[15]  D. Berman,et al.  Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography. , 2004, Journal of the American College of Cardiology.

[16]  Melanie J. Cowan,et al.  The World Health Organization STEPwise Approach to Noncommunicable Disease Risk-Factor Surveillance: Methods, Challenges, and Opportunities. , 2016, American journal of public health.

[17]  N. Yamakita,et al.  Body fatness and fat distribution as predictors of metabolic abnormalities and early carotid atherosclerosis. , 2001, Diabetes care.

[18]  O. Svendsen Should measurement of body composition influence therapy for obesity? , 2003, Acta Diabetologica.

[19]  Udo Hoffmann,et al.  Diagnostic and prognostic value of absence of coronary artery calcification. , 2009, JACC. Cardiovascular imaging.

[20]  C A Emdin,et al.  Apfeltyp erhöht Diabetes- und KHK-Risiko , 2017, DMW - Deutsche Medizinische Wochenschrift.

[21]  P. Schlattmann,et al.  General and abdominal obesity parameters and their combination in relation to mortality: a systematic review and meta-regression analysis , 2013, European Journal of Clinical Nutrition.

[22]  V. Aboyans,et al.  2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). , 2018, Revista espanola de cardiologia.

[23]  Børge G Nordestgaard,et al.  Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial , 2009, The Lancet.

[24]  R. Collins,et al.  Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies , 2009, The Lancet.

[25]  D. Bonaduce,et al.  Prognostic value of coronary artery calcium score and coronary CT angiography in patients with intermediate risk of coronary artery disease , 2012, The International Journal of Cardiovascular Imaging.

[26]  H. Hecht Coronary Artery Calcium Imaging , 2011 .

[27]  P. Cluzel,et al.  HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients. , 2016, Atherosclerosis.

[28]  M. Visser,et al.  What aspects of body fat are particularly hazardous and how do we measure them? , 2006, International journal of epidemiology.

[29]  Relationship between non–high-density lipoprotein cholesterol and carotid atherosclerosis in normotensive and euglycemic Chinese middle-aged and elderly adults , 2017, Lipids in Health and Disease.

[30]  D. Jacobs,et al.  Abdominal obesity and coronary artery calcification in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. , 2007, The American journal of clinical nutrition.

[31]  Daniel S Berman,et al.  Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. , 2007, Journal of the American College of Cardiology.

[32]  E. Oda Metabolic syndrome: its history, mechanisms, and limitations , 2012, Acta Diabetologica.

[33]  K. Watson,et al.  The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. , 2008, Archives of internal medicine.

[34]  E. Barrett-Connor,et al.  A prospective study of abdominal obesity and coronary artery calcium progression in older adults. , 2009, The Journal of clinical endocrinology and metabolism.

[35]  E. V. van Beek,et al.  Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. , 2007, The Journal of clinical endocrinology and metabolism.

[36]  W. James,et al.  WHO recognition of the global obesity epidemic , 2008, International Journal of Obesity.

[37]  K. Strissel,et al.  Immune regulators of inflammation in obesity-associated type 2 diabetes and coronary artery disease , 2014, Current opinion in endocrinology, diabetes, and obesity.

[38]  Paul Schoenhagen,et al.  Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. , 2005, The New England journal of medicine.

[39]  W. Currenti,et al.  High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes. , 2017, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[40]  A. Briasoulis,et al.  Association between various anthropometric measures of obesity and markers of subclinical atherosclerosis , 2016, Expert review of cardiovascular therapy.

[41]  M. Blaha,et al.  Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. , 2009, Atherosclerosis.

[42]  S. R. Ferreira,et al.  Methods of estimation of visceral fat: advantages of ultrasonography. , 2003, Obesity research.

[43]  Klaus Mann,et al.  Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. , 2010, Journal of the American College of Cardiology.

[44]  S. Grundy,et al.  Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[45]  P. Ridker,et al.  Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. , 2001, The American journal of cardiology.

[46]  S. Virani,et al.  Novel markers of inflammation in atherosclerosis , 2008, Current atherosclerosis reports.

[47]  A. Khera,et al.  The association of differing measures of overweight and obesity with prevalent atherosclerosis: the Dallas Heart Study. , 2007, Journal of the American College of Cardiology.

[48]  E. Lonn,et al.  The differential association between various anthropometric indices of obesity and subclinical atherosclerosis. , 2009, Atherosclerosis.

[49]  J. J. Rivera,et al.  Association Between Obesity, High-Sensitivity C-Reactive Protein ≥2 mg/L, and Subclinical Atherosclerosis: Implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[50]  A. Sharma,et al.  Obesity, hypertension and insulin resistance , 2005, Acta Diabetologica.

[51]  Daniel S Berman,et al.  Impact of coronary artery calcium scanning on coronary risk factors and downstream testing the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) prospective randomized trial. , 2011, Journal of the American College of Cardiology.

[52]  Moyses Szklo,et al.  Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2008, Archives of internal medicine.

[53]  Obesity in Adults,et al.  Identification, Evaluation, and Treatment of Overweight and Obesity , 2021, Obesity Prevention and Treatment.

[54]  S. Piro,et al.  HbA1c Identifies Subjects With Prediabetes and Subclinical Left Ventricular Diastolic Dysfunction , 2017, The Journal of clinical endocrinology and metabolism.

[55]  V. Mooser,et al.  Surrogate Markers for Atherosclerosis in Overweight Subjects With Atherogenic Dyslipidemia: The GEMS Project , 2008, Angiology.

[56]  H. Hecht Coronary artery calcium scanning: past, present, and future. , 2015, JACC. Cardiovascular imaging.